top
BRAINLIFE NEWSLETTER
Volume 3, Number 28 - 17 July 2004

Volume 3
Archive


Contents


Epidemiology & Risk Factors
Etiology & Pathogenesis
Overall Management
Prognosis & Outcome
Treatment

Epidemiology & Risk Factors


Paul Graham Fisher, Peter C. Burger, Charles G. Eberhart
Biologic Risk Stratification of Medulloblastoma: The Real Time Is Now 
Journal of Clinical Oncology, Vol 22, No 6 (March 15), 2004: pp. 971-974. 


Etiology & Pathogenesis


Ivanchuk SM, Rutka JT
The cell cycle: accelerators, brakes, and checkpoints
Neurosurgery. 2004 Mar;54(3):692-9; discussion 699-700. 


Overall Management


Fotopoulou A, Solms M, Turnbull O
Wishful reality distortions in confabulation: a case report
Neuropsychologia. 2004;42(6):727-44. 

Kan P, Gottfried O, Blumenthal DT, Townsend JJ, Drozd-Borysiuk E, Brothman AR, Jensen RL
Oligodendroglioma and juvenile pilocytic astrocytoma presenting as synchronous primary brain tumors. Case report with histological and molecular differentiation of the tumors and review of the literature
J Neurosurg. 2004 Apr;100(4):700-5. 


Prognosis & Outcome


Fleckenstein K, Hof H, Lohr F, Wenz F, Wannenmacher M
Prognostic factors for brain metastases after whole brain radiotherapy. Data from a single institution
Strahlenther Onkol. 2004 May;180(5):268-73. 


Treatment


Agarwala SS, Kirkwood JM, Gore M, Dreno B, Thatcher N, Czarnetski B, Atkins M, Buzaid A, Skarlos D, Rankin EM
Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study
 J Clin Oncol. 2004 Jun 1;22(11):2101-7. 

Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
Lancet. 2004 May 22;363(9422):1665-72. 

Chen B, Ahmed T, Mannancheril A, Gruber M, Benzil DL
Safety and efficacy of high-dose chemotherapy with autologous stem cell transplantation for patients with malignant astrocytomas
Cancer. 2004 May 15;100(10):2201-7. 

Chinot OL, Barrie M, Frauger E, Dufour H, Figarella-Branger D, Palmari J, Braguer D, Hoang-Xuan K, Moktari K, Peragut JC, Martin PM, Grisoli F
Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations
Cancer. 2004 May 15;100(10):2208-14. 

Maira G, Anile C, Albanese A, Cabezas D, Pardi F, Vignati A
The role of transsphenoidal surgery in the treatment of craniopharyngiomas
J Neurosurg. 2004 Mar;100(3):445-51. 

Jeremy N. Rich & Darell D. Bigner
Development Of Novel Targeted Therapies In The Treatment Of Malignant Glioma
Nature Reviews Drug Discovery 3, 430 -446 (May 2004 Vol 3 No 5

bottom


HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
| BL Newsletter |
Children's Corner | E-mail Alerts | Journals | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP